AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Slate News
Well, Now: The Full Truth About Ozempic
Jul 14, 2024
Dr. Fatima Cody Stanford discusses GLP-1 agonist drugs and their impact on obesity medicine. Topics include the mechanisms and benefits of drugs like Ozempic, challenges with compounding pharmacies, and the importance of individualized treatment plans for weight management.
49:39
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- GLP-1 agonist drugs like Ozempic revolutionized obesity medicine by promoting weight loss through metabolic improvements.
- Affordability of GLP-1 drugs, such as Ozempic, remains a significant barrier for patients despite their efficacy in treating obesity.
Deep dives
The Impact of Semaglutide Injection in Weight Loss Approval
The approval of semaglutide injection, specifically indicated for weight loss in adults with obesity or classified as overweight with weight-related conditions, has significantly changed the landscape of obesity medicine, with drugs like Wigovi and Manjaro being used in treating at least 13% of American adults.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode